Evidence map›Paper›PMID 41084161›Full record

ArticleEpidemiology and psychiatric sciences2025

Mental health symptoms and associated factors for general population at the stable, recurrence, and end-of-emergency stages of the COVID-19 pandemic: a repeated national cross-sectional study.

Shu Wang, Yuan Zhang, Wei Ding, Yao Meng, Huiting Hu, Yuguang Guan, Xianwei Zeng, Zhenhua Liu, Fangang Meng, Minzhong Wang and 1 more

Abstract read
In one paragraph

Article in Epidemiology and psychiatric sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shu WangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yuan ZhangNeonatal Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wei DingDepartment of Public Health, Liaocheng People's Hospital, Liaocheng, China.
Yao MengDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Huiting HuDepartment of Neurology, Heze Mudan People's Hospital, Heze, China.
Yuguang GuanDepartment of Neurosurgery, SanBo Brain Hospital, Capital Medical University, Beijing, China.
Xianwei ZengDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China.
Zhenhua LiuSleep Medicine Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Fangang MengDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Minzhong WangDepartment of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Jianguo ZhangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0003-2266-6500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe COVID-19 pandemic exacerbated psychological distress, but limited information is available on the shifts in mental health symptoms and their associated factors across different stages. This study was conducted to more reliably estimate shifts in mental health impacts and to identify factors associated with symptoms at different pandemic stages.

methodsWe performed a national repeated cross-sectional study at stable (2021), recurrence (2022), and end-of-emergency (2023) stages based on representative general national population with extensive geographic coverage. Anxiety, depression, post-traumatic stress disorder (PTSD) and insomnia symptoms were evaluated by GAD-7, PHQ-9, IES-R and ISI scales, respectively, and their associated factors were identified via multivariable linear regression.

resultsGenerally, 42,000 individuals were recruited, and 36,218, 36,097 and 36,306 eligible participants were included at each stage. The prevalence of anxiety, depression and insomnia symptoms increased from 13.7-16.4% at stable to 17.3-22.2% at recurrence and decreased to 14.5-18.6% at end of emergency, while PTSD symptom continuously increased from 5.1% to 7.6% and 9.2%, respectively (all significant,

conclusionsMental health symptoms increased when pandemic recurred, and could remain after end-of-emergency, requiring prolonged interventions. Several key factors associated with mental symptoms and their variations were identified at different pandemic stages, suggesting different at-risk populations.

Indexed as

AnxietyCOVID-19DepressionMental HealthSleep Initiation and Maintenance DisordersStress Disorders, Post-TraumaticAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPandemicsPrevalenceRecurrenceanxietyCOVID-19depressioninsomniamental healthpandemicpost-traumatic stress disorderrisk factor

Identifiers

PMID41084161
PMCPMC12555081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.